Table 1 Prevalence of visual impairment in singular ocular diseases from TriNetX.

From: Characterization and prevalence of ocular comorbidities and risk of legal blindness across the United States

Disease

Number with disease age 40 + (per 100,000)

Number with disease all ages (per 100,000)

Percent with VI within disease all ages

DR

426,497 (831)

443,105 (490)

12.63

Glaucoma

708,244 (1379)

732,324 (810)

14.73

Uveitis

124,584 (243)

167,372 (185)

12.64

Neovascular AMD

92,465 (180)

92,849 (103)

21.24

Non-neovascular AMD

199,515 (389)

200,140 (221)

15.28

RVO

66,267 (129)

67,669 (75)

17.76

  1. Total TriNetX Population: 90,380,108.
  2. TriNetX Population Age 40+: 51,345,226.
  3. DR diabetic retinopathy, RVO retinal vein occlusion, AMD age-related macular degeneration, VI visual impairment.
Back to article page